BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29789392)

  • 1. FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1-defective cells.
    Tomida J; Takata KI; Bhetawal S; Person MD; Chao HP; Tang DG; Wood RD
    EMBO J; 2018 Jun; 37(12):. PubMed ID: 29789392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice.
    Findlay S; Heath J; Luo VM; Malina A; Morin T; Coulombe Y; Djerir B; Li Z; Samiei A; Simo-Cheyou E; Karam M; Bagci H; Rahat D; Grapton D; Lavoie EG; Dove C; Khaled H; Kuasne H; Mann KK; Klein KO; Greenwood CM; Tabach Y; Park M; Côté JF; Masson JY; Maréchal A; Orthwein A
    EMBO J; 2018 Sep; 37(18):. PubMed ID: 30154076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An OB-fold complex controls the repair pathways for DNA double-strand breaks.
    Gao S; Feng S; Ning S; Liu J; Zhao H; Xu Y; Shang J; Li K; Li Q; Guo R; Xu D
    Nat Commun; 2018 Sep; 9(1):3925. PubMed ID: 30254264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells.
    Dev H; Chiang TW; Lescale C; de Krijger I; Martin AG; Pilger D; Coates J; Sczaniecka-Clift M; Wei W; Ostermaier M; Herzog M; Lam J; Shea A; Demir M; Wu Q; Yang F; Fu B; Lai Z; Balmus G; Belotserkovskaya R; Serra V; O'Connor MJ; Bruna A; Beli P; Pellegrini L; Caldas C; Deriano L; Jacobs JJL; Galanty Y; Jackson SP
    Nat Cell Biol; 2018 Aug; 20(8):954-965. PubMed ID: 30022119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.
    Gupta R; Somyajit K; Narita T; Maskey E; Stanlie A; Kremer M; Typas D; Lammers M; Mailand N; Nussenzweig A; Lukas J; Choudhary C
    Cell; 2018 May; 173(4):972-988.e23. PubMed ID: 29656893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 53BP1 cooperation with the REV7-shieldin complex underpins DNA structure-specific NHEJ.
    Ghezraoui H; Oliveira C; Becker JR; Bilham K; Moralli D; Anzilotti C; Fischer R; Deobagkar-Lele M; Sanchiz-Calvo M; Fueyo-Marcos E; Bonham S; Kessler BM; Rottenberg S; Cornall RJ; Green CM; Chapman JR
    Nature; 2018 Aug; 560(7716):122-127. PubMed ID: 30046110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAM35A/SHLD2/RINN2: A novel determinant of double strand break repair pathway choice and genome stability in cancer.
    Fackrell K; Bobins L; Parul ; Tomida J
    Environ Mol Mutagen; 2020 Aug; 61(7):709-715. PubMed ID: 32306447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 53BP1-RIF1-shieldin counteracts DSB resection through CST- and Polα-dependent fill-in.
    Mirman Z; Lottersberger F; Takai H; Kibe T; Gong Y; Takai K; Bianchi A; Zimmermann M; Durocher D; de Lange T
    Nature; 2018 Aug; 560(7716):112-116. PubMed ID: 30022158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H4K20me2 distinguishes pre-replicative from post-replicative chromatin to appropriately direct DNA repair pathway choice by 53BP1-RIF1-MAD2L2.
    Simonetta M; de Krijger I; Serrat J; Moatti N; Fortunato D; Hoekman L; Bleijerveld OB; Altelaar AFM; Jacobs JJL
    Cell Cycle; 2018; 17(1):124-136. PubMed ID: 29160738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The shieldin complex mediates 53BP1-dependent DNA repair.
    Noordermeer SM; Adam S; Setiaputra D; Barazas M; Pettitt SJ; Ling AK; Olivieri M; Álvarez-Quilón A; Moatti N; Zimmermann M; Annunziato S; Krastev DB; Song F; Brandsma I; Frankum J; Brough R; Sherker A; Landry S; Szilard RK; Munro MM; McEwan A; Goullet de Rugy T; Lin ZY; Hart T; Moffat J; Gingras AC; Martin A; van Attikum H; Jonkers J; Lord CJ; Rottenberg S; Durocher D
    Nature; 2018 Aug; 560(7716):117-121. PubMed ID: 30022168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REV7 counteracts DNA double-strand break resection and affects PARP inhibition.
    Xu G; Chapman JR; Brandsma I; Yuan J; Mistrik M; Bouwman P; Bartkova J; Gogola E; Warmerdam D; Barazas M; Jaspers JE; Watanabe K; Pieterse M; Kersbergen A; Sol W; Celie PHN; Schouten PC; van den Broek B; Salman A; Nieuwland M; de Rink I; de Ronde J; Jalink K; Boulton SJ; Chen J; van Gent DC; Bartek J; Jonkers J; Borst P; Rottenberg S
    Nature; 2015 May; 521(7553):541-544. PubMed ID: 25799992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient Tumors.
    Barazas M; Gasparini A; Huang Y; Küçükosmanoğlu A; Annunziato S; Bouwman P; Sol W; Kersbergen A; Proost N; de Korte-Grimmerink R; van de Ven M; Jonkers J; Borst GR; Rottenberg S
    Cancer Res; 2019 Feb; 79(3):452-460. PubMed ID: 30530501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone chaperone ASF1 acts with RIF1 to promote DNA end joining in BRCA1-deficient cells.
    Tang M; Chen Z; Wang C; Feng X; Lee N; Huang M; Zhang H; Li S; Xiong Y; Chen J
    J Biol Chem; 2022 Jun; 298(6):101979. PubMed ID: 35472331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress.
    Chroma K; Mistrik M; Moudry P; Gursky J; Liptay M; Strauss R; Skrott Z; Vrtel R; Bartkova J; Kramara J; Bartek J
    Oncogene; 2017 Apr; 36(17):2405-2422. PubMed ID: 27841863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIP13 regulates DNA repair pathway choice through REV7 conformational change.
    Clairmont CS; Sarangi P; Ponnienselvan K; Galli LD; Csete I; Moreau L; Adelmant G; Chowdhury D; Marto JA; D'Andrea AD
    Nat Cell Biol; 2020 Jan; 22(1):87-96. PubMed ID: 31915374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of RIF1 by SCAI Allows BRCA1-Mediated Repair.
    Isobe SY; Nagao K; Nozaki N; Kimura H; Obuse C
    Cell Rep; 2017 Jul; 20(2):297-307. PubMed ID: 28700933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds.
    Zimmer J; Tacconi EMC; Folio C; Badie S; Porru M; Klare K; Tumiati M; Markkanen E; Halder S; Ryan A; Jackson SP; Ramadan K; Kuznetsov SG; Biroccio A; Sale JE; Tarsounas M
    Mol Cell; 2016 Feb; 61(3):449-460. PubMed ID: 26748828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice.
    Escribano-Díaz C; Orthwein A; Fradet-Turcotte A; Xing M; Young JT; Tkáč J; Cook MA; Rosebrock AP; Munro M; Canny MD; Xu D; Durocher D
    Mol Cell; 2013 Mar; 49(5):872-83. PubMed ID: 23333306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p31
    Sarangi P; Clairmont CS; Galli LD; Moreau LA; D'Andrea AD
    Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26795-26803. PubMed ID: 33051298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIF1 acts in DNA repair through phosphopeptide recognition of 53BP1.
    Setiaputra D; Escribano-Díaz C; Reinert JK; Sadana P; Zong D; Callen E; Sifri C; Seebacher J; Nussenzweig A; Thomä NH; Durocher D
    Mol Cell; 2022 Apr; 82(7):1359-1371.e9. PubMed ID: 35216668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.